Fourth, although we adjusted for several clinical variables and striatal dopamine transporter availability in the multivariate linear regression analysis, there were still other possible confounders that can affect the outcomes of DBS, including genotypes of PD, motor phenotypes of PD, postoperative lead location and DBS programming parameters that were not considered in the analysis of our study. This evidence concerns the gene SLC6A3 and Parkinson disease.